Market Tracker

10/31 7:05pm ET

Theravance Inc (NASDAQ:THRX)

16.02
Data as of Oct 31
 -0.19 / -1.17%
Today’s Change
15.56
Today|||52-Week Range
32.88
-44.21%
Year-to-Date

Today’s Trading

Previous close16.21
Today’s open16.46
Day’s range15.58 - 16.61
Volume1,052,816
Average volume (3 months)807,044
Market cap$1.9B
Dividend yield6.24%
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+35.93%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book6.04

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.15-1.06%
LCILannett Company Inc+0.83+1.49%
CLVSClovis Oncology Inc+0.50+0.85%
IPXLImpax Laboratories I...+0.35+1.22%
Data as of 4:04pm ET, 10/31/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts